Calithera Biosciences, Inc is a biotechnology business based in the US. Calithera Biosciences shares (CALA) are listed on the NASDAQ and all prices are listed in US Dollars. Calithera Biosciences employs 92 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Calithera Biosciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CALA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Calithera Biosciences stock price (NASDAQ: CALA)Use our graph to track the performance of CALA stocks over time.
Calithera Biosciences shares at a glance
|Latest market close||$2.28|
|52-week range||$1.78 - $5.96|
|50-day moving average||$2.12|
|200-day moving average||$2.49|
|Wall St. target price||$5.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.23|
Buy Calithera Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Calithera Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Calithera Biosciences price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||8.06%|
|3 months (2021-04-28)||-1.72%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Calithera Biosciences financials
|Gross profit TTM||$-71,015,000|
|Return on assets TTM||-41.29%|
|Return on equity TTM||-77.62%|
|Market capitalisation||$154 million|
TTM: trailing 12 months
Shorting Calithera Biosciences shares
There are currently 2.2 million Calithera Biosciences shares held short by investors – that's known as Calithera Biosciences's "short interest". This figure is 28.3% down from 3.1 million last month.
There are a few different ways that this level of interest in shorting Calithera Biosciences shares can be evaluated.
Calithera Biosciences's "short interest ratio" (SIR)
Calithera Biosciences's "short interest ratio" (SIR) is the quantity of Calithera Biosciences shares currently shorted divided by the average quantity of Calithera Biosciences shares traded daily (recently around 1.2 million). Calithera Biosciences's SIR currently stands at 1.89. In other words for every 100,000 Calithera Biosciences shares traded daily on the market, roughly 1890 shares are currently held short.
However Calithera Biosciences's short interest can also be evaluated against the total number of Calithera Biosciences shares, or, against the total number of tradable Calithera Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Calithera Biosciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Calithera Biosciences shares in existence, roughly 30 shares are currently held short) or 0.0354% of the tradable shares (for every 100,000 tradable Calithera Biosciences shares, roughly 35 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Calithera Biosciences.
Find out more about how you can short Calithera Biosciences stock.
Calithera Biosciences share dividends
We're not expecting Calithera Biosciences to pay a dividend over the next 12 months.
Have Calithera Biosciences's shares ever split?
Calithera Biosciences's shares were split on a 1:48 basis on 18 September 2014. So if you had owned 48 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Calithera Biosciences shares – just the quantity. However, indirectly, the new 4700% higher share price could have impacted the market appetite for Calithera Biosciences shares which in turn could have impacted Calithera Biosciences's share price.
Calithera Biosciences share price volatility
Over the last 12 months, Calithera Biosciences's shares have ranged in value from as little as $1.78 up to $5.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Calithera Biosciences's is 1.6148. This would suggest that Calithera Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Calithera Biosciences overview
Calithera Biosciences, Inc. , a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate is CB-839, an inhibitor of glutaminase, which is in Phase II clinical trial to treat solid tumors. The company also offers INCB001158, an oral inhibitor of arginase that is in Phase I/II clinical trial for the treatment of hematology and oncology. The company is also developing CB-280, an oral arginase inhibitor that is in Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and CB-708, an orally administered small molecule inhibitor of CD73, as well as CB-668, an inhibitor of the enzyme IL4I1. It has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare.
Stocks similar to Calithera Biosciences
Calithera Biosciences in the news
Interesting CALA Call Options For March 2022
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Implied Volatility Surging for Calithera Biosciences (CALA) Stock Options
Frequently asked questionsWhat percentage of Calithera Biosciences is owned by insiders or institutions?
Currently 0.706% of Calithera Biosciences shares are held by insiders and 77.53% by institutions. How many people work for Calithera Biosciences?
Latest data suggests 92 work at Calithera Biosciences. When does the fiscal year end for Calithera Biosciences?
Calithera Biosciences's fiscal year ends in December. Where is Calithera Biosciences based?
Calithera Biosciences's address is: 343 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Calithera Biosciences's ISIN number?
Calithera Biosciences's international securities identification number is: US13089P1012 What is Calithera Biosciences's CUSIP number?
Calithera Biosciences's Committee on Uniform Securities Identification Procedures number is: 13089P101
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert